HCA
ADAP

Harbor Capital Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Harbor Capital Advisors’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-188,070
Closed -$297K – 726
2024
Q1 		$297K Buy
188,070
+40,338
+27% +$63.7K 0.04% 523
2023
Q4 		$117K Buy
147,732
+13,317
+10% +$10.6K 0.02% 407
2023
Q3 		$105K Buy
134,415
+21,899
+19% +$17.1K 0.02% 414
2023
Q2 		$104K Buy
+112,516
New +$104K 0.02% 428